Can Benfotiamine Help Alzheimer’s Disease? This is what scientists are trying to determine. According to Alzheimer's News Today, a large clinical trial has received $45 million in U.S. funding to evaluate the efficacy of benfotiamine — a lab-made precursor of thiamine or vitamin B1 — in slowing the cognitive decline of those with mild Alzheimer’s disease or mild cognitive impairment.

Keywords: Alzheimer's disease, benfotiamine, type3diabetes mayo clinic

Meta Description: Researchers are referring to Alzheimer’s disease as “Type 3 diabetes” and the primary RISK for developing Type 3 diabetes is having Type 2 diabetes.